The CEO of Regenetek Research Inc for treatment collects thousands of dollars from Canadian patients.
Lee Chuckry, 47 is one among the patients questioning the research and credentials. He has been living with MS for nearly two decades.
His efforts led him to Regenetek, and it's CEO: Doug Broeska. For $35,000, Regenetek patients were flown to India for the procedure. Chuckry was one of the participants. But when he returned home, he says his symptoms worsened.
In testimonials, MS patients attributed miraculous medical improvement to experimental stem cell therapy.
"I'm going to call Doug a con artist," Chuckry said. "You are preying on people who are desperate. They are looking for hope of any sort."
The University of Manitoba where Broeska claimed he received his degree and doctorate from has said there is no record of him graduating. He operates as a medical researcher without proper credentials.
None of the allegations have been proven in court, and Broeska has not been criminally charged. In a statement to CTV News, Regenetek wrote, "Its clinical study is being mischaracterized in the media."
While clinical trials are underway in Canada, doctors do not require patients to pay thousands of dollars to take part and no stem cell therapy has received Health Canada approval for treatment of Multiple Sclerosis.
- » News Central
- » Popular News
- » Latest Health News
- » News Category A-Z (500+)
- » Health News and Press Release
- » News Archive
- » News Photo Gallery
- » Lifestyle and Wellness
- » Health Watch
- » Health In Focus
- » Celebrating Life
- » Breaking Health News
- » News From Other Resources
- » India Special
- » News Video Gallery
- » Medindia Exclusive - Interviews and In depth Reports